Mangiferin and Cancer: Mechanisms of Action

• Main Authors: Fuchsia Gold-Smith, Alyssa Fernandez, Karen Bishop
• Format: Article
• Language: English
• Published: MDPI AG 2016-06-01
• Series: Nutrients
• Subjects: mangiferin; cancer; inflammation; NFκB; oxidative stress; cell cycle; combination therapy; nutraceuticals; bioavailability; hallmarks of cancer
• Online Access: http://www.mdpi.com/2072-6643/8/7/396

Mangiferin, a bioactive compound derived primarily from Anacardiaceae and Gentianaceae families and found in mangoes and honeybush tea, has been extensively studied for its therapeutic properties. Mangiferin has shown promising chemotherapeutic and chemopreventative potential. This review focuses on the effect of mangiferin on: (1) inflammation, with respect to NFκB, PPARү and the immune system; (2) cell cycle, the MAPK pathway G2/M checkpoint; (3) proliferation and metastasis, and implications on β-catenin, MMPs, EMT, angiogenesis and tumour volume; (4) apoptosis, with a focus on Bax/Bcl ratios, intrinsic/extrinsic apoptotic pathways and telomerase activity; (5) oxidative stress, through Nrf2/ARE signalling, ROS elimination and catalase activity; and (6) efficacy of chemotherapeutic agents, such as oxaliplatin, etoposide and doxorubicin. In addition, the need to enhance the bioavailability and delivery of mangiferin are briefly addressed, as well as the potential for toxicity.